Skip to main content
. 2018 Dec 26;18(3):504–519. doi: 10.1074/mcp.RA118.000922

Fig. 5.

Fig. 5.

CRMP-2 as a target of DMF modification in neural cells. A, MS/MS spectrum from rat primary neuron extracts after DMF treatment showing the DMF modified Cys504 of CRMP-2 in the peptide GLYDGPVCDMFEVSVTPK. B, MS/MS spectrum from rat primary astrocyte extracts after DMF treatment showing the MMF modified Cys504 of CRMP-2 in the peptide GLYDGPVCMMFEVSVTPK.